Jump to content
Health NZ Taranaki Lab Manual

Tests:SARS-Cov-2 NAAT (POCT): Difference between revisions

Department
Point of care
Tests:SARS-Cov-2 NAAT (POCT)
Pam Chung (talk | contribs)
No edit summary
Pam Chung (talk | contribs)
No edit summary
Line 1: Line 1:
{{DISPLAYTITLE: SARS-CoV-2 NAAT (POCT)}}  
\{{DISPLAYTITLE: SARS-CoV-2 NAAT (POCT)}}  
[[Category:Tests]]
[[Category:Tests]]
[[Category:POCT]]
[[Category:POCT]]
Line 16: Line 16:
|-
|-
|'''Availability'''
|'''Availability'''
|
|Only available at Taranaki Base ED and Hawera ED
|-
|-
|'''Turnaround Time'''
|'''Turnaround Time'''
|2 – 24 hours from receipt 
|Once Patients sample has been placed on the analyser, results can be obtained no longer than 15 minutes
 
Results may be delayed out of routine business hours.
 
Urgent requests will be prioritised
|-
|-
|'''Stability – Add test'''
|'''Stability – Add test'''
|
|Dry swab sample must be processed ASAP
|-
|-
! colspan="2" |
! colspan="2" |
== Specimen Requirements ==
== '''Specimen Requirements''' ==
|-
|-
|Specimen  
|'''Specimen'''
|Swab
|Nasal or Nasopharyngeal swab
|-
|-
|Preferred
|'''Preferred'''
|Nasopharyngeal swab in VTM (Viral transport  medium) 
|Nasopharyngeal swab  
|-
|-
|Acceptable
|'''Acceptable'''
|
|Only sample taken with <u>dry swab</u> included in the ID NOW test kits.
|-
|-
|Unacceptable
|'''Unacceptable'''
|
|Any other swabs not as part of the testing kit
|-
|-
|Specimen Transportation
|'''Specimen Transportation'''
|ASAP to Laboratory    
|Room temperature/ambient and ASAP to the analyser for processing    
|-
|Paediatric Requirements 
|Paediatric nasopharyngeal swab in VTM (Viral transport  medium) 
|-
|-
! colspan="2" |
! colspan="2" |
== Aliquot Requirements ==
== '''Test Information''' ==
|-
|Sample
|
|-
|Preferred Volume
|
|-
|Minimum Volume
|
|-
|-
|Aliquot Transportation
|'''Test Method'''
|If there is a delay in getting sample to the  laboratory, please store sample chilled (2 - 8 degrees Celsius)
|ID NOW - COVID 19 (ABBOTT)
|-
Real-time isothermal Nucleic Acid Amplification Test (NAAT)
! colspan="2" |
== Clinical Information ==
|-
|-
|Reference Intervals
|'''Units of Measurement'''
|Results will be reported as Novel Coronavirus RNA PCR  DETECTED or NOT Detected. 
|Qualitative
 
Ct values are available on request.
 
Specimens that fail for technical reasons will be  tested by another platform or a repeat sample requested, this will mean a  delay in results
|-
|-
|Test Method
|'''Reference Intervals'''
|Real-time RT-PCR test on the GeneXpert analyser for the  qualitative detection of nucleic acid from the SARS-CoV-2 virus.  
|Results, reported as SARS-CoV-2 POCT NAAT either as - DETECTED or NOT Detected.
 
No Ct values are available for this test
Note if a “QUAD” swab is requested then Influenza A +  B, RSV, and SARS-CoV-2 are tested.
|-
|-
|Advanced Notice
|'''uncertainty of Measurement'''
|Not required 
|N/A
|-
|-
|Patient Preparation
|'''Additional Informationm'''
|To minimise inhibition in the assay, please ensure the patients blow their nose prior to taking a nasopharyngeal swab.   
|To minimise inhibition in the testing, please ensure the patients' blow their nose prior to taking either Nasal or Nasopharyngeal swab. 
Specimens that fail for technical reasons can be tested by another platform in the Laboratory. A repeat sample is to be requested using a QUAD swab (VTM  swab)
|-
|-
! colspan="2" |
! colspan="2" |
== Comments ==
== '''Comments''' ==
|-
|-
| colspan="2" |Influenza A/B and RSV, Full Respiratory Multiplex and Bordetella pertussis PCR may be carried out on the same nasopharyngeal swab.
| colspan="2" |Please note that a negative SARS-CoV-2 point-of-care test may not fully exclude COVID-19 infection. A second sample for repeat POC or laboratory PCR can be considered if there is a high clinical suspicion of infection.
 
''Please note:'' Testing of the full respiratory multiplex assay does not have the same turnaround time as the Influenza A/B, RSV test as the sample is forwarded to a reference laboratory. 
|}
|}
{{DocMeta
{{DocMeta

Revision as of 10:24, 2 October 2025

\

Overview

Department Point of Care (POCT)
Test Code N/A
Synonyms COVID-19, SARS-CoV-2, Novel Coronavirus, ID NOW - cCOVID
Availability Only available at Taranaki Base ED and Hawera ED
Turnaround Time Once Patients sample has been placed on the analyser, results can be obtained no longer than 15 minutes
Stability – Add test Dry swab sample must be processed ASAP

Specimen Requirements

Specimen Nasal or Nasopharyngeal swab
Preferred Nasopharyngeal swab
Acceptable Only sample taken with dry swab included in the ID NOW test kits.
Unacceptable Any other swabs not as part of the testing kit
Specimen Transportation Room temperature/ambient and ASAP to the analyser for processing

Test Information

Test Method ID NOW - COVID 19 (ABBOTT)

Real-time isothermal Nucleic Acid Amplification Test (NAAT)

Units of Measurement Qualitative
Reference Intervals Results, reported as SARS-CoV-2 POCT NAAT either as - DETECTED or NOT Detected.

No Ct values are available for this test

uncertainty of Measurement N/A
Additional Informationm To minimise inhibition in the testing, please ensure the patients' blow their nose prior to taking either Nasal or Nasopharyngeal swab. 

Specimens that fail for technical reasons can be tested by another platform in the Laboratory. A repeat sample is to be requested using a QUAD swab (VTM swab)

Comments

Please note that a negative SARS-CoV-2 point-of-care test may not fully exclude COVID-19 infection. A second sample for repeat POC or laboratory PCR can be considered if there is a high clinical suspicion of infection.
Owner Pam Chung (Pchung)
Last reviewed 2 Oct 2025
Next review Overdue, 2 Oct 2026